21 – 30 of 72
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Galectin-3 inhibition by a small-molecule inhibitor reduces both pathological corneal neovascularization and fibrosis
(
- Contribution to journal › Article
-
Mark
Limited tumor tissue drug penetration contributes to primary resistance against angiogenesis inhibitors
(
- Contribution to journal › Article
-
Mark
Androgen dependent mechanisms of pro-angiogenic networks in placental and tumor development
(
- Contribution to journal › Article
-
Mark
Cytochalasin B-induced membrane vesicles convey angiogenic activity of parental cells
(
- Contribution to journal › Article
-
Mark
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression
(
- Contribution to journal › Article
- 2016
-
Mark
Pathophysiological Mechanisms and Diagnostic Markers in Alzheimer’s Disease
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli
(
- Contribution to journal › Article
-
Mark
ITPP treatment of RG2 glioblastoma in a rat model
(
- Contribution to journal › Article
-
Mark
Targeting tumour vasculature by inhibiting activin receptor-like kinase (ALK)1 function
(
- Contribution to journal › Article
-
Mark
Compound genetically engineered mouse models of cancer reveal dual targeting of ALK1 and endoglin as a synergistic opportunity to impinge on angiogenic TGF-β signaling
(
- Contribution to journal › Article